HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug-Spiked Supplements Spread During US Holidays; Excess Yohimbine In Gorilla Root Juice

Executive Summary

Reminding consumers in somewhat an end-of-year tradition about drug-spiked supplements, FDA also says “dangerous” levels of yohimbine found in Green Gorilla Root Juice prompted recall. Agency also suggests retailers get more involved in preventing sales of drug-spiked products labeled as supplements.

You may also be interested in...



US FDA Concern Rekindled After Finding ED-Spiked Supplements Sold On Amazon

NJ firms S&B Shopper and Namoo Enterprise recall products after FDA tests found undisclosed erectile dysfunction drugs sildenafil and tadalafil. FDA officials Imperial Extreme 2000 and Namoo’s PremierZen Black 5000 capsules on Amazon.

Amazon Flexes E-Commerce Heft By Imposing Quality-Control Requirements For Supplements

Amazon requires firms selling supplements on its site in the US to demonstrate their products comply with FDA regulations for labeling and GMPs. Marketers that don’t submit documentation face removal of their products from the site.

Spiked Supplement Holiday Deliveries Stopped By Import Examinations

FDA alerts consumers and health care providers to 13 products found in examinations of international mail shipments to contain sildenafil and one with the banned drug sibutramine.

Topics

UsernamePublicRestriction

Register

RS150828

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel